EVO Stock Summary and Trading Ideas (Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share | NASDAQ:EVO)

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share trades on the NASDAQ stock market under the symbol EVO.

As of April 10, 2026, EVO stock price climbed to $2.63 with 51,517 million shares trading.

EVO has a beta of 1.43, meaning it tends to be more sensitive to market movements. EVO has a correlation of 0.10 to the broad based SPY ETF.

EVO has a market cap of $934.94 million. This is considered a Small Cap stock.

Last quarter Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share reported $295 million in Revenue and $.05 earnings per share. This beat revenue expectation by $42 million and exceeded earnings estimates by $.03.

In the last 3 years, EVO traded as high as $13.49 and as low as $2.31.

EVO has underperformed the market in the last year with a return of -14.1%, while the SPY ETF gained +30.9%. In the last 3 month period, EVO fell short of the market, returning -28.1%, while SPY returned -1.8%. However, in the most recent 2 weeks EVO has outperformed the stock market by returning +8.7%, while SPY returned +7.2%.

EVO support price is $2.53 and resistance is $2.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EVO shares will trade within this expected range on the day.